Suggested Topics within your search.
Showing 1,401 - 1,420 results of 1,444 for search 'Patient’s Medication Knowledge', query time: 0.08s Refine Results
  1. 1401
  2. 1402

    Research Progress of Nerve Mobilization in Basic and Clinical Rehabilitation by Shuo LUAN, Quanshou LING, Miaoshang ZENG, Anni LIN, Yingping JIANG

    Published 2019-06-01
    “…For the symptomatic patients, the changes of mechanical tension and movement sequence should be identified before the individualized NM treatment. …”
    Get full text
    Article
  3. 1403

    Should the Food and Drug Administration Limit Placebo-Controlled Trials? by Max Goodman, Connor Pedersen

    Published 2022-07-01
    “… [3] WMA Declaration of Helsinki – ethical principles for medical research involving human subjects. The World Medical Association. http://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. …”
    Get full text
    Article
  4. 1404
  5. 1405
  6. 1406
  7. 1407
  8. 1408
  9. 1409

    Effectiveness and safety of percutaneous endoscopic debridement and drainage for spinal infections: a systematic review and meta-analysis by Guozhong Zhou, Xiaorong Liu, Zhi Liang, Xuesong Chen, Chao Song

    Published 2025-02-01
    “…Abstract Background Spinal infections (SI) typically manifest with and pose a growing medical challenge. However, current evidence for treating SI is limited and inconclusive. …”
    Get full text
    Article
  10. 1410
  11. 1411
  12. 1412
  13. 1413
  14. 1414
  15. 1415
  16. 1416
  17. 1417

    Unravelling the role of secretory Immnuoglobulin-A in COVID-19: a multicentre study in nursing homes during the first wave by Rafael Bielza, Patricia Pérez, Nuria García, Laura Ballesteros-Sanabria, Rosa María Martínez, Azam Ghazi, Clara Hernando, María Victoria Rodríguez, Israel J. Thuissard, Cristina Andreu-Vázquez, José Manuel Bautista

    Published 2024-10-01
    “…Results At the time of sample collection, 274 residents (89.8%) exhibited “induced” SIgA-S1 levels (≥ 57.6 U/mL), 46 (15.1%) tested positive for PCR SARS-CoV-2, and 170 (57%) had experienced COVID-19 symptoms. “Induced” SIgA-S1 patients were more likely to be symptomatic (60.3% vs. 29%; p < 0.001) and exhibited upper respiratory tract symptoms more frequently (25.1% vs. 6.5%; p = 0.020) compared to “non-induced” patients. …”
    Get full text
    Article
  18. 1418
  19. 1419
  20. 1420